Embecta Corp. provided revenue guidance for the last six months of fiscal year 2022. For the period, the company expects total revenue of approximately $555 million, representing a decrease of approximately 7.0%, as compared to total revenue of $596 million for the last six months of fiscal year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.57 USD | -0.88% | -1.31% | -28.31% |
05-16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
05-09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.31% | 790M | |
-4.77% | 179B | |
+4.10% | 113B | |
-3.85% | 67.88B | |
+5.19% | 52.03B | |
+5.54% | 43.3B | |
+4.94% | 41.79B | |
+23.81% | 32.49B | |
+15.56% | 25.65B | |
-5.06% | 24.55B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Revenue Guidance for the Last Six Months of Fiscal Year 2022